Results from a phase I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer. (Q54674601)
Jump to navigation
Jump to search
scientific article published on 13 May 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Results from a phase I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer. |
scientific article published on 13 May 2010 |
Statements
Results from a phase I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer. (English)
Sonia A Perez
Nikoletta L Kallinteris
Stratos Bisias
Panagiotis K Tzonis
Katerina Georgakopoulou
Marighoula Varla-Leftherioti
Michael Papamichail
Anastasios Thanos
Eric von Hofe
Constantin N Baxevanis
13 May 2010
16
13
3495-3506